We are global leader in the laboratory diagnostics market, specializing in the immunodiagnostics and molecular diagnostics segments. For over 50 years our Group has been developing, producing and commercializing diagnostic tests: we support clinical laboratory needs and activities, providing solutions that are reliable, innovative, fully automated and standardized. We continually invest in Research & Development, using our own distinctive expertise in the field to deliver a high level of innovation.
Group Websites
Clinical Areas
We offer the broadest range of specialty tests available in the immunodiagnostics market.
Discover All Areas
Discover Our Menu
LIAISON® XL
LIAISON® XL is the fully automated chemiluminescence analyzer, performing complete sample
processing (sample pre-dilutions, sample and reagent dispensing, incubations, wash processes,
etc.) as well as measurement and evaluation.
The innovative features of the system allow LIAISON® XL to improve efficiency in the
immunoassay laboratories: fully automated solution, quality of results, flexible configuration,
high efficiency.
Discover All Systems
Worldwide Presence
Our Group consists of 24 companies and 5 foreign branches, with offices across 5 continents and manufacturing premises producing its tests in 6 sites around the world.
Where we are
News
01/31/2019
DiaSorin launches FDA-Cleared LIAISON® Calprotectin test in the US market
09/17/2018
DiaSorin launches the new LIAISON® QUANTIFERON®-TB GOLD PLUS ASSAY as an aid for latent tuberculosis
07/27/2018
DiaSorin launches Hepatitis Delta (Hdv) test on LIAISON® XL platform
05/23/2017
DiaSorin launches the new LIAISON® SHBG test for the diagnosis of androgen-related disorders